Corcept Therapeutics Incorporated (CORT) Plunges 7.75% on January 24

Corcept Therapeutics Incorporated (CORT) Plunges 7.75% on January 24

Corcept Therapeutics Incorporated (CORT) had a rough trading day for Thursday January 24 as shares tumbled 7.75%, or a loss of $-1.16 per share, to close at $13.81. After opening the day at $14.93, shares of Corcept Therapeutics Incorporated traded as high as $15.03 and as low as $13.49. Volume was 1.71 million shares over 11,040 trades, against an average daily volume of n/a shares and a total float of 115.47 million.

As a result of the decline, Corcept Therapeutics Incorporated now has a market cap of $1.59 billion.

The stock has a P/E Ratio of 12.4.

Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.

Corcept Therapeutics Incorporated is based out of Menlo Park, CA and has some 136 employees. Its CEO is Joseph K. Belanoff.

Share:
Scroll Up
error: Content is protected !!